From: Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties
Compound
∆G and binding affinity (Kcal/mol)
8d
 − 9.5
PRD400
 − 8.5